Live attenuated virus vaccines
Live attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics
8
Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses
13
Live Attenuated Vaccines: Influenza, Rotavirus and Varicella Zoster Virus
33
Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines
12
Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and Ferrets
8
Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines
6
Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus
8
Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines
12
Influenza Viruses with Rearranged Genomes as Live-Attenuated Vaccines
10
Complexities in predicting the immunogenicity of live attenuated influenza vaccines
7
In Vitro Analysis of Virus Particle Subpopulations in Candidate Live-Attenuated Influenza Vaccines Distinguishes Effective from Ineffective Vaccines
8
Pathogenic Conversion of Live Attenuated Simian Immunodeficiency Virus Vaccines Is Associated with Expression of Truncated Nef
8
Development of Live-Attenuated Arenavirus Vaccines Based on Codon Deoptimization
11
Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines
15
General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines
12
Persistence of Antibody After Administration of Monovalent and Combined Live Attenuated Measles, Mumps, and Rubella Virus Vaccines
9
Isolation of an Infectious Endogenous Retrovirus in a Proportion of Live Attenuated Vaccines for Pets
5
Cross Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines
12
The Matrix Gene Segment Destabilizes the Acid and Thermal Stability of the Hemagglutinin of Pandemic Live Attenuated Influenza Virus Vaccines
11
Local and systemic antibody responses in high risk adults given live attenuated and inactivated influenza A virus vaccines
8